Deal Watch: Takeda Continues Transaction Spree With Four More Deals

 
• By Joseph Haas and Lubna Ahmed

Takeda's recent deals include a license in Asian for Tesaro's PARP inhibitor Zejula. Meanwhile, Japanese rival Mitsubishi Tanabe is paying roughly $1bn to acquire Israel's NeuroDerm.

DealWatch_1200x675

More from Business

More from Scrip